Welcome to our Investor Center. Our center is designed to provide you with convenient access to company information. For additional information on our portfolio of product candidates, please visit Pipeline.
SAN DIEGO, Sep 07, 2010 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the following investor conferences:
The Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 14, 2010, at 12:30 p.m. Eastern Time at The New York Palace Hotel in New York City.
...
SAN DIEGO, Aug 09, 2010 (BUSINESS WIRE) --ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company
utilizing innovative technology to fuel drug discovery and clinical
development of novel treatments for central nervous system disorders,
today reported its unaudited financial results for the second quarter
ended June 30, 2010.
ACADIA reported a net loss of $4.3 million, or $0.11 per common share,
for the second quarter of 2010 compared to...
ACADIA to Host Conference Call and Webcast on Monday, August 9, 2010,
at 5:00 p.m. Eastern Time
SAN DIEGO, Aug 02, 2010 (BUSINESS WIRE) --ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company
utilizing innovative technology to fuel drug discovery and clinical
development of novel treatments for central nervous system disorders,
today announced that it will report its unaudited financial results for
the second quarter ended June 30, 2010...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
